LEADER 02530oam  2200541   450 
001 9910298323503321
005 20190911112726.0
010   $a3-642-41293-9
024 7 $a10.1007/978-3-642-41293-6
035   $a(OCoLC)868310179
035   $a(MiFhGG)GVRL6WTJ
035   $a(EXLCZ)993710000000074678
100   $a20130909d2014      uy             0
101 0 $aeng
135   $aurun|---uuuua
181   $ctxt
182   $cc
183   $acr
200 00$aBiopatent law $eEuropean vs. US patent law /$fUlrich Storz, Martin Quodbach, Scott D. Marty, Derek E. Constantine, Matthew Parker
205   $a1st ed. 2014.
210  1$aNew York :$cSpringer,$d2014.
215   $a1 online resource (viii, 69 pages) $cillustrations (chiefly color), portraits
225 1 $aSpringerBriefs in Biotech Patents,$x2192-9912
300   $aDescription based upon print version of record.
311   $a3-642-41292-0 
320   $aIncludes bibliographical references.
327   $aPreface -- Ulrich Storz: Patentability Requirements of Biotech Patents -- Martin Quodbach: Law Enforcement of Biotech Patents -- Scott D. Marty, Derek E. Constantine and Matthew Parker: Particular: Aspects of US Patent Law in Biotechnologies -- About the Authors.
330   $aSpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.
410  0$aSpringerBriefs in biotech patents.
606   $aBiotechnology$xPatents
606   $aBiotechnology$xLaw and legislation$zUnited States
606   $aBiotechnology$xLaw and legislation$zEuropean Union countries
615  0$aBiotechnology$xPatents.
615  0$aBiotechnology$xLaw and legislation
615  0$aBiotechnology$xLaw and legislation
676   $a343.099
700   $aStorz$b Ulrich$4aut$4http://id.loc.gov/vocabulary/relators/aut$01064618
702   $aStorz$b Ulrich$f1969-
702   $aQuodbach$b Martin
702   $aMarty$b Scott D.
702   $aConstantine$b Derek E.
702   $aParker$b Matthew
801  0$bMiFhGG
801  1$bMiFhGG
906   $aBOOK
912   $a9910298323503321
996   $aBiopatent law$93871300
997   $aUNINA